Contact dermatitis from levobunolol eyedrops.
Erdmann
S
S
Department of Dermatology, University Hospitals RWTH Aachen, Germany.
Hertl
M
M
Merk
H F
HF
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D001762:Blepharitis / Q000139:chemically induced*; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D002040:Levobunolol / Q000009:adverse effects* / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D010328:Patch Tests
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D002040:Levobunolol